112 related articles for article (PubMed ID: 1963249)
1. Expression of bovine leukaemia virus envelope gene by recombinant vaccinia viruses.
Kumar S; Andrew ME; Boyle DB; Brandon RB; Lavin MF; Daniel RC
Virus Res; 1990 Oct; 17(2):131-42. PubMed ID: 1963249
[TBL] [Abstract][Full Text] [Related]
2. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
3. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
[TBL] [Abstract][Full Text] [Related]
4. Agar gel immunodiffusion analysis using baculovirus-expressed recombinant bovine leukemia virus envelope glycoprotein (gp51/gp30(T-)).
Lim SI; Jeong W; Tark DS; Yang DK; Kweon CH
J Vet Sci; 2009 Dec; 10(4):331-6. PubMed ID: 19934599
[TBL] [Abstract][Full Text] [Related]
5. Development and in vitro characterization of recombinant vaccinia viruses expressing bovine leukemia virus gp51 in combination with bovine IL4 or IL12.
Von Beust BR; Brown WC; Estes DM; Zarlenga DS; McElwain TF; Palmer GH
Vaccine; 1999 Jan; 17(4):384-95. PubMed ID: 9987178
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus.
Ohishi K; Maruyama T; Shida H; Nishimaki J; Miki K; Sagata N; Ikawa Y; Sugimoto M
Vaccine; 1988 Oct; 6(5):428-32. PubMed ID: 2848378
[TBL] [Abstract][Full Text] [Related]
7. Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein.
Ohishi K; Suzuki H; Maruyama T; Yamamoto T; Funahashi S; Miki K; Ikawa Y; Sugimoto M
Am J Vet Res; 1990 Aug; 51(8):1170-3. PubMed ID: 2167028
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae.
Legrain M; Portetelle D; Dumont J; Burny A; Hilger F
Gene; 1989 Jul; 79(2):227-37. PubMed ID: 2551774
[TBL] [Abstract][Full Text] [Related]
9. Recombinant viral vaccines for enzootic bovine leucosis.
Daniel RC; Gatei MH; Good MF; Boyle DB; Lavin MF
Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():399-404. PubMed ID: 8270269
[TBL] [Abstract][Full Text] [Related]
10. Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay.
De Giuseppe A; Feliziani F; Rutili D; De Mia GM
Clin Diagn Lab Immunol; 2004 Jan; 11(1):147-51. PubMed ID: 14715562
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.
Ohishi K; Suzuki H; Yamamoto T; Maruyama T; Miki K; Ikawa Y; Numakunai S; Okada K; Ohshima K; Sugimoto M
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1887-92. PubMed ID: 1651982
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant.
Ludvíková V; Kunke D; Hamsíková E; Kutinová L; Vonka V
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1445-9. PubMed ID: 1646285
[TBL] [Abstract][Full Text] [Related]
13. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.
Shida H; Hinuma Y; Hatanaka M; Morita M; Kidokoro M; Suzuki K; Maruyama T; Takahashi-Nishimaki F; Sugimoto M; Kitamura R
J Virol; 1988 Dec; 62(12):4474-80. PubMed ID: 3184271
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of vaccinia virus promoter activity in fowlpox and vaccinia virus recombinants.
Prideaux CT; Kumar S; Boyle DB
Virus Res; 1990 Apr; 16(1):43-57. PubMed ID: 2161593
[TBL] [Abstract][Full Text] [Related]
15. Activity of a fowlpox virus late gene promoter in vaccinia and fowlpox virus recombinants.
Kumar S; Boyle DB
Arch Virol; 1990; 112(3-4):139-48. PubMed ID: 2165765
[TBL] [Abstract][Full Text] [Related]
16. Expression of a bovine leukaemia virus envelope fusion protein in E. coli.
Zajac V; Sláviková K
Folia Biol (Praha); 1989; 35(1):35-41. PubMed ID: 2541029
[TBL] [Abstract][Full Text] [Related]
17. Purification by Strep-Tactin affinity chromatography of a delete envelope gp51 protein of Bovine Leukaemia virus expressed in Sf21 insect cells.
De Giuseppe A; Forti K; Feliziani F; Severi G; Cagiola M
Protein J; 2010 Apr; 29(3):153-60. PubMed ID: 20232124
[TBL] [Abstract][Full Text] [Related]
18. Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs.
López N; Scolaro L; Rossi C; Jácamo R; Candurra N; Pujol C; Damonte EB; Franze-Fernández MT
J Gen Virol; 2000 May; 81(Pt 5):1273-81. PubMed ID: 10769070
[TBL] [Abstract][Full Text] [Related]
19. Expression of the bovine leukemia virus transactivator protein p34 by a recombinant vaccinia virus.
Willems L; Letellier C; Gonze M; Martin R; Kettmann R; Burny A; Meulemans G
Vet Immunol Immunopathol; 1989 Oct; 22(3):201-11. PubMed ID: 2560852
[TBL] [Abstract][Full Text] [Related]
20. Expression of env sequences of the bovine leukemia virus (BLV) in the yeast Saccharomyces cerevisiae.
Brantl S; Eldarov MA; Rössler H; Drescher B; Lang H; Rosenthal S; Skryabin KG
Yeast; 1988 Mar; 4(1):47-59. PubMed ID: 2849260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
